Literature DB >> 10927162

Contrast-enhanced magnetic resonance imaging of the breast.

T H Helbich1.   

Abstract

Contrast-enhanced magnetic resonance (MR) imaging is increasingly used as a complementary diagnostic modality in breast imaging. The sensitivity of MR imaging of the breast for malignancy has consistently been reported to be excellent. The specificity has been rather variable. Study methods and imaging techniques are not standardized and there is still a great deal of uncertainty about MR imaging's place in clinical practice. Nevertheless, radiologists should be familiar with the current technique and the varying MR appearance of breast tumors to improve the accuracy of this method. This paper reviews the techniques for breast MR imaging, the pathopysiologic basis of contrast enhancement in breast tumors, and the current knowledge about detection and differentiation of breast tumors. In addition, future directions for breast MR imaging are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10927162     DOI: 10.1016/s0720-048x(00)00200-x

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  20 in total

Review 1.  Stereotactic and ultrasound-guided breast biopsy.

Authors:  T H Helbich; W Matzek; M H Fuchsjäger
Journal:  Eur Radiol       Date:  2003-11-13       Impact factor: 5.315

2.  [Functional and molecular imaging of breast tumors].

Authors:  K Pinker; P Brader; G Karanikas; K El-Rabadi; W Bogner; S Gruber; M Reisegger; S Trattnig; T H Helbich
Journal:  Radiologe       Date:  2010-11       Impact factor: 0.635

3.  Contrast-enhanced dual energy mammography with a novel anode/filter combination and artifact reduction: a feasibility study.

Authors:  Thomas Knogler; Peter Homolka; Mathias Hörnig; Robert Leithner; Georg Langs; Martin Waitzbauer; Katja Pinker-Domenig; Sabine Leitner; Thomas H Helbich
Journal:  Eur Radiol       Date:  2015-09-15       Impact factor: 5.315

4.  Dynamic breast MR imaging: is parametric mapping superior to image subtraction in lesion detection?

Authors:  Kathinka D Kurz; Hans-Jörg Wittsack; Reinhart Willers; Dirk Blondin; Ulrich Mödder; Andreas Saleh
Journal:  Eur Radiol       Date:  2007-06-16       Impact factor: 5.315

5.  Contrast-enhanced 3.0-T breast MRI for characterization of breast lesions: increased specificity by using vascular maps.

Authors:  A C Schmitz; N H G M Peters; W B Veldhuis; A M Fernandez Gallardo; P J van Diest; G Stapper; R van Hillegersberg; W P Th M Mali; M A A J van den Bosch
Journal:  Eur Radiol       Date:  2007-09-20       Impact factor: 5.315

6.  Molecular Imaging in Breast Cancer - Potential Future Aspects.

Authors:  Katja Pinker; Wolfgang Bogner; Stephan Gruber; Peter Brader; Siegfried Trattnig; Georgios Karanikas; Thomas H Helbich
Journal:  Breast Care (Basel)       Date:  2011-04-29       Impact factor: 2.860

7.  Genomic profiling in locally advanced and inflammatory breast cancer and its link to DCE-MRI and overall survival.

Authors:  Sharareh Siamakpour-Reihani; Kouros Owzar; Chen Jiang; Peter M Scarbrough; Oana I Craciunescu; Janet K Horton; Holly K Dressman; Kimberly L Blackwell; Mark W Dewhirst
Journal:  Int J Hyperthermia       Date:  2015-03-26       Impact factor: 3.914

8.  Novel technology of multimodal ultrasound tomography detects breast lesions.

Authors:  G Zografos; D Koulocheri; P Liakou; M Sofras; S Hadjiagapis; M Orme; V Marmarelis
Journal:  Eur Radiol       Date:  2012-09-16       Impact factor: 5.315

9.  Differentiation of BIRADS-4 small breast lesions via Multimodal Ultrasound Tomography.

Authors:  G Zografos; P Liakou; D Koulocheri; I Liovarou; M Sofras; S Hadjiagapis; M Orme; V Marmarelis
Journal:  Eur Radiol       Date:  2014-09-14       Impact factor: 5.315

10.  Characteristic performance evaluation of a photon counting Si strip detector for low dose spectral breast CT imaging.

Authors:  Hyo-Min Cho; William C Barber; Huanjun Ding; Jan S Iwanczyk; Sabee Molloi
Journal:  Med Phys       Date:  2014-09       Impact factor: 4.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.